Zoetis inc stock.

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Is Zoetis Inc worth watching? 12 stock analysts on Stockchase covered Zoetis Inc In the last year. It is a trending stock that is worth watching. What is Zoetis Inc ...tendered in exchange for 400,985,000 shares of common stock of Zoetis Inc. (“Zoetis”), representing all of the Zoetis stock then owned by Pfizer (the “Exchange”). Pursuant to the Exchange, tendering Pfizer shareholders received 0.9898 of a share of Zoetis common stock in exchange for each share of PfizerThe estimated Net Worth of Catherine A. Knupp is at least $17 Million dollars as of 10 November 2021. Catherine Knupp owns over 10,000 units of Zoetis Inc stock worth over $7,683,611 and over the last 11 years he sold ZTS stock worth over $6,035,956. In addition, he makes $3,311,220 as Executive Vice President and President - Research …Another stock his team likes Zoetis , an animal healthcare company. ... American telecom giant Verizon Communications Inc. (NYSE:VZ) closed at $37.50 with …Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...

Zoetis may alter or terminate the terms of the FP Guarantee at any time and for any reason. GBF-00659. Beef news & updates. August 3, 2022. Press Release Zoetis Recieves Expanded Labels For Beef Implant Products. August 29, 2022. Press Release Zoetis Continues Support of Folds of Honor Mission With Donation.Price Performance Review of ZTS. On Friday, Zoetis Inc [NYSE:ZTS] saw its stock jump 0.82% to $162.23. On the same session, the stock had its day’s lowest price of $159.37, but rose to a high of $164.72. Over the last five days, the stock has gained 3.97%. Zoetis Inc shares have risen nearly 10.70% since the year began.Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ...

Aug 8, 2023 · Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ...

tendered in exchange for 400,985,000 shares of common stock of Zoetis Inc. (“Zoetis”), representing all of the Zoetis stock then owned by Pfizer (the “Exchange”). Pursuant to the Exchange, tendering Pfizer shareholders received 0.9898 of a share of Zoetis common stock in exchange for each share of PfizerSanjay owns over 2,779 units of Zoetis Inc stock worth over $462,426 and over the last 14 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals.Posted by u/stockinvest-us - 1 vote and no comments

Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...

Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement.

Nov 24, 2023 · Zoetis : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: ZTS | Nyse Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement.Zoetis Inc. (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Nyse: ZTS | NyseMay 5, 2022 · Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022. 0.92%. $5.88B. ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Sanjay owns over 2,779 units of Zoetis Inc stock worth over $462,426 and over the last 14 years he sold ZTS stock worth over $0. In addition, he makes $330,000 as Independent Director at Zoetis Inc. Wallmine is a radically better financial terminal. Sign up in seconds, it's free!Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ...Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ...Zoetis shares fell 11% on the day of Q3 results, as investors reacted to a 3.7% decline in its Adjusted EPS. See why we reiterate our buy rating on ZTS stock.Latest news about Zoetis Inc. Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. Nov. 28. CI. Zoetis Insider Sold Shares Worth $2,298,856, According to a Recent SEC Filing. Nov. 21. MT. Zoetis Insider Sold Shares Worth $163,796, According to a Recent SEC Filing.

Zoetis Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Zoetis Inc. Stock | ZTS | US98978V1035For the Zoetis Inc forecast (traded under symbol ZTS) ... Zoetis Inc: Stock buyback: ZTS buyback: Website: www.zoetis.com: Sector: Drugs & Pharmaceuticals: Number of ETFs Holding ZTS: 100 (see which ones) Total Market Value Held by ETFs: $9,326,985,263.3: Total Market Capitalization:

The estimated Net Worth of Paul Bisaro is at least $37.6 Milión dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,215,457 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Dec 1, 2023 · Complete Zoetis Inc. stock information by Barron's. View real-time ZTS stock price and news, along with industry-best analysis. Zoetis Inc. (NYSE:ZTS) today announced that its Board of Directors has authorized a $1.5 billion multi-year share repurchase program as part of its long-term capital allocation plans. The shares are expected to be repurchased at the discretion of management over a multi-year period, and the program can be cancelled at any time.Zoetis Inc Stock Ownership - Who owns Zoetis? Add to Watchlist. Overview Forecast Earnings Dividend Ownership. Insider buying vs selling Have Zoetis Inc insiders been buying or selling? Buy. Sell. Name Role Date Shares Price Value; Kristin C. Peck: Chief Executive Officer: 2023-11-21: 13,000: $46.09: $599.17k Buy. Kristin C. Peck: Chief ...Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);The stock of Zoetis Inc (ZTS) has gone up by 3.52% for the week, with a 7.35% rise in the past month and a -3.00% drop in the past quarter. The volatility ratio for the week is 2.00%, and the volatility levels for the past 30 days are 2.50% for ZTS. The simple moving average […]Nov 29, 2023 · The high in the last 52 weeks of Zoetis stock was 194.99. According to the current price, Zoetis is 90.29% away from the 52-week high. What are analysts forecasts for Zoetis stock? Zoetis Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Zoetis Inc. Stock | ZTS | US98978V1035

US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.

The estimated Net Worth of Paul Bisaro is at least $38.1 million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,738,448 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.

Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.Nov 29, 2023 · Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | Nyse Zoetis Inc. - Hold . ... A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. In general, ...Analyst Report: Zoetis Inc Find the latest Zoetis Inc. (ZTS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance. Nov 13, 2023. finance.yahoo.com . Zoetis Inc. (ZTS) Q3 2023 Earnings Conference Call Transcript47 minutes ago. Company profile page for Zoetis Inc including stock price, company news, press releases, executives, board members, and contact information.PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies.In 2023, 135 honorees were recognized, spanning 19 countries and 46 industries. Zoetis is one of …Discover historical prices for T stock on Yahoo Finance. View daily, weekly or monthly format back to when AT&T Inc. stock was issued.Get Zoetis Inc (ZTS.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis. 1 Based on internal estimates and publicly available information. Zoetis Media: Bill Price 1-973-443-2742 (o) [email protected]. Christina Lood 1-973-822-7249 (o) …Dec 1, 2023 · Zoetis Inc. is an animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. Mar 13, 2023 · PARSIPPANY, N.J., March 13, 2023 -- ( BUSINESS WIRE )-- Zoetis Inc. (NYSE:ZTS) has been recognized by Ethisphere, a global leader in defining and advancing the standards of ethical business ... Instagram:https://instagram. star bulk dividendvo2 apple watchstepstone venture capitalmargin or cash account webull Nov 29, 2023 · The high in the last 52 weeks of Zoetis stock was 194.99. According to the current price, Zoetis is 90.29% away from the 52-week high. What are analysts forecasts for Zoetis stock? Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ... sdy etfbroadcom stock prediction The company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ... chase refinance interest rates Zoetis Inc - Class A (ZTS) stock price prediction is 338.41269225246 USD. The Zoetis Inc - Class A stock forecast is 338.41269225246 USD for 2024 November ...Nov 11, 2022 · Zoetis has repurchased $545m of its stock in Q1-3, equivalent to 0.8% of its current market capitalization. Out of a $3.5bn share repurchase program authorized in December 2021, $3.0bn remained at ...